Bill Behnke Named a “Most Inspiring Business Leader of 2025” by CXO Outlook
We’re proud to share that Bill Behnke, Founder and CEO of Cizzle Bio, Inc., has been recognized in the August issue of CXO Outlook® as one of their “Most Inspiring Business Leaders of 2025.”
The feature highlights Bill’s 30+ year journey in healthcare innovation and his unwavering commitment to transforming early cancer detection. Under his leadership, Cizzle Bio is advancing two groundbreaking blood tests for early-stage cancer:
CIZ1B – a simple, minimally invasive biomarker blood test for early detection with 95% sensitivity and 96% negative predictive value (NPV)
DEX-G2 – a biomarker-based blood test for early-stage gastric cancer with 95% sensitivity, validated in a multicenter clinical trial published in JAMA Surgery
Both tests are designed to address critical gaps in early cancer detection and coming soon to clinical environments in the United States and the Caribbean through our CLIA-certified lab partners.
We’re honored by this recognition and inspired by Bill’s visionary leadership as we continue building a future where early detection is the standard of care.
